David E. Wheadon insider trades: Indivior Pharmaceuticals (INDV) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
and 1 more company
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | INDV | ↑ Buy | 1,771 | $35.39 | $63K | Direct | Jan 7, 2026 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other INDV insiders
Open-market trades in the last 12 months
About David E. Wheadon's insider trades
David E. Wheadon is a director at Indivior Pharmaceuticals (INDV). Since Jan 5, 2026, David has reported 1 open-market purchase worth $63K and no sales on SEC Form 4. In the last 12 months: 1 buy ($63K).
Their filings also include grants and awards (22 filings), shares returned to the company (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every INDV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.